← Leaderboards
Ayma Malik
Rutgers Biomedical And Health Sciences
$89,416
Attributed
$89,416
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $45K · FY2024–25$50K$37.5K$25K$12.5K$0
'24
'25
Funding mix
By agency
NIH$89,416 · 1
By mechanism
F31$89,416 · 1
Top collaborators
No co-investigators on record.
Most similar at Rutgers Biomedical And Health Sciences
Same institution · by research overlap
- Greta Bushnell$1,949,155
Others in their field
Other Rising Stars on “Abuse Liability”
- Taleen Hanania · Psychogenics, Inc.$9,482,040
- Matthew Walentiny · Virginia Commonwealth University$2,894,517
- Georgette Suidan · Cerevel Therapeutics, Llc$2,700,000
- Ruth Huttenhain · University Of California, San Francisco$2,364,012
- Joseph Grieco · Park Therapeutics, Inc.$2,218,061
- Ahmad El Hellani · American University Of Beirut$2,153,195
Research focus
Abuse LiabilityAddictionAlternative SplicingAstrocytesBackBehavioralBrain RegionBrain StemBreathingBreedingCategoriesCause Of DeathCellsCell TypeCodeCombatComplexComprehensionConditional KnockoutCytomegalovirusDependenceDistressDoseAbsence Of Pain Sensation
Grant awards (2)
Exploring the Role of Alternatively Spliced Variants of the Mu Opioid Receptor Gene, Oprm1, in Opioid-Induced Respiratory Depression in Gene Targeted Rat Models$44,990
F31 · FY2025 · DA · contact PI
Exploring the Role of Alternatively Spliced Variants of the Mu Opioid Receptor Gene, Oprm1, in Opioid-Induced Respiratory Depression in Gene Targeted Rat Models$44,426
F31 · FY2024 · DA · contact PI